Q2 2024 · 13F-HR
Octagon Capital Advisors LPholdings as filed
Filed 2024-08-14 · accession 0001839435-24-000005
$636.3M
Reported value
46
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $110.5M | 17.4% | 2,880,880 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $45.2M | 7.10% | 1,746,667 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $44.8M | 7.04% | 1,140,060 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $43.6M | 6.85% | 650,216 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $41.7M | 6.55% | 1,180,798 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $33.5M | 5.26% | 1,803,304 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $27.4M | 4.31% | 1,895,200 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $22.1M | 3.47% | 488,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $21.2M | 3.33% | 2,345,075 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $17.5M | 2.75% | 690,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $16.8M | 2.63% | 250,000 | CALL | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $16.6M | 2.61% | 2,425,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $15.8M | 2.48% | 1,580,249 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $15.5M | 2.44% | 2,153,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $13.4M | 2.11% | 350,000 | CALL | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $10.8M | 1.69% | 260,000 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $10.2M | 1.61% | 4,572,222 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $9.5M | 1.50% | 1,093,503 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $9.3M | 1.46% | 1,364,400 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $8.3M | 1.30% | 9,187,883 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $8.1M | 1.27% | 620,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $8.0M | 1.26% | 2,576,200 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $7.6M | 1.20% | 4,263,701 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $7.1M | 1.11% | 9,800,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $7.0M | 1.10% | 600,000 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $6.9M | 1.09% | 3,220,263 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $6.6M | 1.04% | 283,372 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $6.5M | 1.03% | 287,500 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $6.0M | 0.94% | 376,117 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $5.5M | 0.87% | 2,391,114 | Common | SOLE |
| 23256X100 | — | CYBIN INC | $5.0M | 0.79% | 18,604,650 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $3.4M | 0.53% | 1,333,650 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $3.4M | 0.53% | 2,250,000 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.3M | 0.53% | 176,000 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.40% | 250,000 | Common | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $2.1M | 0.34% | 736,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $2.0M | 0.32% | 747,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $2.0M | 0.31% | 992,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $2.0M | 0.31% | 400,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $1.7M | 0.27% | 520,800 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $1.4M | 0.22% | 240,000 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $1.3M | 0.20% | 431,600 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $929,037 | 0.15% | 767,799 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $890,600 | 0.14% | 292,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $772,630 | 0.12% | 465,440 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $612,480 | 0.10% | 176,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.